
What We’re Reading: FDA Advisers Back Alzheimer Drug; Drug Shortage Record; Protecting Rural Hospitals From Cyberattacks
Eli Lilly’s Alzheimer disease drug donanemab unanimously earned the backing of FDA advisers; recent research found 323 active drug shortages in the first 3 months of 2024, marking the highest number since 2001; Microsoft and Google will offer free or discounted cybersecurity services to US rural hospitals to make them less vulnerable to cyberattacks.
Alzheimer Drug Gets Backing From FDA Advisers
Eli Lilly’s Alzheimer disease drug, donanemab, earned the backing of FDA advisers on Monday and is expected to be approved for patients with mild dementia caused by the disease, according to the
Pharmacists Report Highest Drug Shortage Number Since 2001
Recent research by the
Microsoft, Google to Help Protect US Rural Hospitals From Cyberattacks
Microsoft and Google announced Monday that they will offer free or discounted cybersecurity services to US rural hospitals amid the increase in cyberattacks, according to
Related to this article








